IL6 and atherosclerosis: The present study demonstrated that EPA suppressed the VEGF-induced activation of a proinflammatory cytokine (IL-6) and some chemokines (MCP-1 and IL-8), delineating a possible role for EPA in the treatment of atherosclerosis due to anti-inflammatory properties.